Sort
39,280 grants matching “leukemia”
Identifying genetic mechanisms in T-ALL with an inducible Sleeping Beauty system
$311,250Adam J. Dupuy · University Of Iowa · R01 · FY2010 · CA
Mechanism and Regulation of eIF6 in Translation
$311,246Sofia Origanti · Saint Louis University · R01 · FY2022 · GM
Project 1: Increasing therapeutic efficacy in isocitrate dehydrongenase (IDH)âmutant acute myeloid leukemia (AML)
$311,223Ross L Levine · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
$311,223Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Project 3: Therapeutic inhibition of splicing through inhibition of protein arginine methylation in leukemia
$311,223Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Intervention of Immune Tolerance by Small Molecules
$311,223Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Project 2: Defining and exploiting genetic dependencies in complex karyotype AML
$311,223Scott W Lowe · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
HLA-Releasing Metalloproteinase in Allograft Rejection
$311,200Public Health Research Institute · R01 · FY2005 · AI
Disentanglement of the MLL-WDR5 Protein-Protein Recognition Events
$311,200Liviu Movileanu · Syracuse University · R01 · FY2020 · GM
Transcription Factor Regulation by the BCR/ABL Oncogene
$311,178Bruno Calabretta · Thomas Jefferson University · R01 · FY2009 · CA
Transcription Factor Regulation by the BCR/ABL Oncogene
$311,178Bruno Calabretta · Thomas Jefferson University · R01 · FY2010 · CA
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
$311,165Raphael Kopan · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA
B-cell repertoires in chronic lymphocytic leukemia
$311,150Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2012 · CA
B-cell repertoires in chronic lymphocytic leukemia
$311,150Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2011 · CA
ROLE OF PBX AND PRE B ACUTE LYMPHOBLASTOID LEUKEMIA
$311,142University Of California San Diego · R01 · FY2001 · CA
ETIOLOGY &PATHOGENESIS OF MURINE GRAFT VS-HOST DISEASE
$311,138Thomas Jefferson University · R01 · FY2001 · HL
Retroviral Integration & HDAC inhibitors
$311,136Monica J Roth · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2009 · GM
Disentanglement of the MLL-WDR5 Protein-Protein Recognition Events
$311,121Liviu Movileanu · Syracuse University · R01 · FY2019 · GM
ROCK II-mediated regulation of centrosome duplication / centrosome amplification
$311,110Kenji Fukasawa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · GM
Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors
$311,097Andrew S Kraft · University Of Arizona · R01 · FY2015 · CA
GAG Protein/RNA Interactions in the HIV Lifecycle
$311,097Emory University · R01 · FY2005 · AI
Role of POZ-zinc finger proteins in tumorigenesis.
$311,080Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2013 · CA
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
$311,063Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Gene Therapy for Lung Disease in a Ferret Model of Cystic Fibrosis
$311,060John F Engelhardt · University Of Iowa · P01 · FY2015 · HL
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS
$311,047James D Griffin · Dana-Farber Cancer Inst · P01 · FY2009 · CA